Roderick De Greef - Aug 17, 2021 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role
CFO
Signature
/s/ Roderick de Greef
Stock symbol
BLFS
Transactions as of
Aug 17, 2021
Transactions value $
-$2,073,229
Form type
4
Date filed
8/19/2021, 08:00 PM
Previous filing
Jul 1, 2021
Next filing
Sep 30, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLFS Common Stock Sale -$538K -12K -6.86% $44.81 163K Aug 17, 2021 Direct F1, F2
transaction BLFS Common Stock Sale -$537K -12K -7.37% $44.75 151K Aug 18, 2021 Direct F1, F3
transaction BLFS Common Stock Sale -$457K -10.2K -6.79% $44.64 141K Aug 18, 2021 Direct F4
transaction BLFS Common Stock Sale -$541K -12K -8.53% $45.12 129K Aug 19, 2021 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of May 20, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.26 to $45.68, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.48 to $45.26, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4 The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44 to $45.97, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.